Selank vs Cerebrolysin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Selanc, TP-7
Selank is a synthetic seven-amino-acid peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) built from the natural immune peptide tuftsin, with a small chemical tweak to make it last longer in the body. It was developed in Russia as an anti-anxiety and nootropic agent and is approved there for generalized anxiety disorder, but it has no FDA or EMA approval and almost no Western clinical data. The pitch is calm and focus without the sedation, dependence, or withdrawal that come with benzodiazepines.
Also: FPE 1070
Cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by EVER Neuro Pharma in Austria. It is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not FDA-approved in the United States. Despite decades of use abroad, the human evidence remains genuinely contested.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Selank | Cerebrolysin |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Selank seems to work through several overlapping systems rather than one tidy target. It influences GABA signaling, the brain's main calming neurotransmitter system, which likely accounts for its anti-anxiety effect. It also slows the breakdown of enkephalins, the body's own opioid-like peptides involved in mood and stress, which is a mechanism entirely different from benzodiazepines or SSRIs. Animal work additionally points to effects on serotonin and dopamine balance and on BDNF, a growth factor tied to learning and neuron health. These pathways are well documented in rodents; the picture in humans is inferred rather than directly measured. | The proposed idea is that Cerebrolysin's small peptides act like the body's own neurotrophic factors, the molecules such as BDNF and NGF that help neurons survive, grow, and form connections. Researchers hypothesize it engages neurotrophic signaling pathways and may protect neurons from injury and support repair after stroke or brain trauma. It is important to be clear that the exact active components and mechanism are not fully defined, partly because it is a complex biological mixture rather than one purified molecule. So the neurotrophic-mimic story is a plausible hypothesis supported by some lab data, not a precisely mapped pathway. |
| Common Dosing | 250-500 mcg intranasal 2-3x daily 2-3x daily, intranasal | 20-32 mg/day subcutaneous (60mg vial reconstituted in 3 mL bac water = 20 mg/mL) Once or twice daily, split doses above 20 mg into AM/PM, gradual titration |
| Administration | Intranasal spray (most common), subcutaneous injection | Subcutaneous (research) or intravenous/intramuscular (clinical literature) |
| Typical Duration | 14-21 days typical | 8-16 week protocols for research-scale subQ; 10-20 day cycles for clinical IV |
| Best Time to Take | Morning or as needed for anxiety | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Most of the rigorous data is preclinical and Russian. In rodents, Selank shows consistent anxiety-reducing and mild cognitive effects, and one PMC-indexed study found it enhanced diazepam's anti-anxiety effect under chronic stress. The main human clinical reference is a Russian comparative trial by Zozulia, Neznamov, and colleagues in patients with generalized anxiety disorder and neurasthenia, reporting that Selank's anxiolytic effect was comparable to the benzodiazepine medazepam on standard rating scales, with added anti-fatigue benefits and changes in enkephalin activity. The honest caveat: that trial was relatively small, the published English abstract gives qualitative results rather than hard effect sizes and p-values, and it has not been replicated by independent Western groups. So the evidence supports a real but modestly studied anxiolytic, mostly validated within the regulatory system that approved it. | Cerebrolysin has been tested in many human trials, but the quality and consistency of that evidence is the real story. A Cochrane systematic review on vascular dementia (Cui and colleagues, 2019) concluded that intravenous Cerebrolysin may improve cognition and global function, but cautioned the findings were not definitive because of high risk of bias and heterogeneity across studies. Cochrane reviews of acute ischemic stroke have similarly found insufficient or inconclusive evidence and have flagged a possible signal of increased non-fatal serious adverse events in some analyses. The Alzheimer's Drug Discovery Foundation's Cognitive Vitality review rates the human evidence as mixed and far from conclusive. So while it is a real, widely prescribed drug in many countries, the claim that it reliably improves brain outcomes is not established to Western regulatory standards, and many of the supporting trials come from a narrow set of investigators and sponsors. |
Frequently Asked Questions: Selank vs Cerebrolysin
What is the difference between Selank and Cerebrolysin?
Selank is a cognitive peptide that selank is a synthetic seven-amino-acid peptide (thr-lys-pro-arg-pro-gly-pro) built from the natural immune peptide tuftsin, with a small chemical tweak to make it last longer in the body. it was developed in russia as an anti-anxiety and nootropic agent and is approved there for generalized anxiety disorder, but it has no fda or ema approval and almost no western clinical data. the pitch is calm and focus without the sedation, dependence, or withdrawal that come with benzodiazepines. Cerebrolysin is a cognitive peptide that cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by ever neuro pharma in austria. it is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not fda-approved in the united states. despite decades of use abroad, the human evidence remains genuinely contested. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Selank or Cerebrolysin?
Neither is universally "better" - the choice depends on your specific goals. Selank is typically used for cognitive purposes, while Cerebrolysin is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Selank and Cerebrolysin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Selank and Cerebrolysin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.